Agile Therapeutics to Present at the 28th Annual ROTH Conference
10 3월 2016 - 9:46AM
Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty
pharmaceutical company focused on the development and
commercialization of new prescription contraceptive products,
announced today that Al Altomari, President and Chief Executive
Officer will present at the 28th Annual ROTH Conference on Monday,
March 14, 2016 at 7:30 AM Pacific Time.
To access the live and archived webcast of the
presentation, visit the Investor Relations section of Agile
Therapeutics website at www.agiletherapeutics.com. The webcast will
be archived on Agile Therapeutics website for 60 days following the
event.
About Agile
Agile Therapeutics is a women’s health specialty
pharmaceutical company focused on the development and
commercialization of new prescription contraceptive products. Our
product candidates are designed to provide women with contraceptive
options that offer greater convenience and facilitate compliance.
Our lead product candidate, Twirla®, (ethinyl estradiol and
levonorgestrel transdermal system), also known as AG200-15, is a
once-weekly prescription contraceptive patch currently in Phase 3
clinical development. Twirla is based on our proprietary
transdermal patch technology, called Skinfusion®, which is designed
to provide advantages over currently available patches and is
intended to optimize patch adherence and patient
acceptability. For more information, please visit the company
website at www.agiletherapeutics.com.
Contact: Mary Coleman 609-683-1880
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024